LYTIX BIOPHARMA AS

Lytix Biopharma is a clinical-stage biotech company with a highly novel technology platform using host-defense peptide-derived molecules to kill cancer cells and kick start the immune system... With the potential to overcome major challenges in cancer treatment, we aim to improve the outcomes for cancer patients.

Also known as: Lytix Biopharma

Primary location: Oslo Norway